UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 93

Sortiert nach

Baseline comprehensive geriatric assessment is associated with toxicity and survival in elderly metastatic breast cancer patients receiving single-agent chemotherapy: Results from the OMEGA study of the Dutch Breast Cancer Trialists' Group

Breast (Edinburgh), 2014-02, Vol.23 (1), p.81-87

2014

Link zum Volltext

Verfügbarkeit prüfen

CYP2D6 genotype- and endoxifen-guided tamoxifen dose escalation increases endoxifen serum concentrations without increasing side effects

Breast cancer research and treatment, 2015-10, Vol.153 (3), p.583-590

2015

Link zum Volltext

Verfügbarkeit prüfen

Predictive value of geriatric assessment for patients older than 70 years, treated with chemotherapy

Critical reviews in oncology/hematology, 2011-08, Vol.79 (2), p.205-212

2011

Link zum Volltext

Verfügbarkeit prüfen

A randomized phase III study comparing pegylated liposomal doxorubicin with capecitabine as first-line chemotherapy in elderly patients with metastatic breast cancer: results of the OMEGA study of the Dutch Breast Cancer Research Group BOOG

Annals of oncology, 2014-03, Vol.25 (3), p.599-605

2014

Link zum Volltext

Verfügbarkeit prüfen

Clinical Relevance of BCL2, BCL6, and MYC Rearrangements in Diffuse Large B-Cell Lymphoma

Blood, 1998-11, Vol.92 (9), p.3152-3162

1998

Link zum Volltext

Verfügbarkeit prüfen

Clinical Relevance of BCL2, BCL6, and MYC Rearrangements in Diffuse Large B-Cell Lymphoma

Blood, 1998-11, Vol.92 (9), p.3152-3162

1998

Link zum Volltext

Verfügbarkeit prüfen

Prognostic value of geriatric assessment in older patients with advanced breast cancer receiving chemotherapy

Breast (Edinburgh), 2013-10, Vol.22 (5), p.753-760

2013

Link zum Volltext

Verfügbarkeit prüfen

Optimal duration of extended letrozole treatment after 5 years of adjuvant endocrine therapy; results of the randomized phase III IDEAL trial (BOOG 2006–05)

European journal of cancer (1990), 2017-02, Vol.72, p.S9-S9

2017

Link zum Volltext

Verfügbarkeit prüfen

High non-compliance in the use of letrozole after 2.5 years of extended adjuvant endocrine therapy. Results from the IDEAL randomized trial

European journal of surgical oncology, 2012-02, Vol.38 (2), p.110-117

2012

Link zum Volltext

Verfügbarkeit prüfen

Factors that influence treatment decision-making in elderly DLBCL patients: a case vignette study

Annals of hematology, 2015-08, Vol.94 (8), p.1373-1379

2015

Link zum Volltext

Verfügbarkeit prüfen

Patients' preferences for adjuvant chemotherapy in early-stage breast cancer: is treatment worthwhile?

British journal of cancer, 2001-06, Vol.84 (12), p.1577-1585

2001

Link zum Volltext

Verfügbarkeit prüfen

Comorbidity and treatment decision-making in elderly non-Hodgkin's lymphoma patients: a survey among haematologists

Netherlands journal of medicine, 2014-04, Vol.72 (3), p.165-169

2014

Link zum Volltext

Verfügbarkeit prüfen

Slow accrual of elderly patients with metastatic breast cancer in the Dutch multicentre OMEGA study

Breast (Edinburgh), 2013-08, Vol.22 (4), p.556-559

2013

Link zum Volltext

Verfügbarkeit prüfen

249 Feasibility and Toxicities Associated with PEG Doxo Versus Capecitabine as First-line Chemotherapy in Elderly Metastatic Breast Cancer (MBC) Patients; Results From the Randomized OMEGA Study of the Dutch Breast Cancer Trialists’ Group (BOOG)

European journal of cancer (1990), 2012-03, Vol.48, p.S115-S115

2012

Link zum Volltext

Verfügbarkeit prüfen

Patterns of care in Dutch postmenopausal patients with hormone-sensitive early breast cancer participating in the Tamoxifen Exemestane Adjuvant Multinational (TEAM) trial

Annals of oncology, 2010-05, Vol.21 (5), p.974-982

2010

Link zum Volltext

Verfügbarkeit prüfen

Improved survival for patients with large B-cell lymphoma after introduction of rituximab

Netherlands journal of medicine, 2009-09, Vol.67 (8), p.355-358

2009

Link zum Volltext

Verfügbarkeit prüfen

Pulmonary coccidioidomycosis: import illness and the importance of travel history

Netherlands journal of medicine, 2009-11, Vol.67 (10), p.353-355

2009

Link zum Volltext

Verfügbarkeit prüfen

Prognostic factors for the feasibility of chemotherapy and the Geriatric Prognostic Index (GPI) as risk profile for mortality before chemotherapy in the elderly

Acta oncologica, 2016-01, Vol.55 (1), p.15-23

2016

Link zum Volltext

Verfügbarkeit prüfen

Abstract S1-04: Optimal duration of extended letrozole treatment after 5 years of adjuvant endocrine therapy; results of the randomized phase III IDEAL trial (BOOG 2006-05)

Cancer research (Chicago, Ill.), 2017-02, Vol.77 (4_Supplement), p.S1-S1-04

2017

Link zum Volltext

Verfügbarkeit prüfen

104 - Optimal duration of extended letrozole treatment after 5 years of adjuvant endocrine therapy; results of the randomized phase III IDEAL trial (BOOG 2006–05)

European journal of cancer (1990), 2017-02, Vol.72, p.S9-S9

2017

Link zum Volltext

Verfügbarkeit prüfen

Watery diarrhoea : an unusual manifestation of breast cancer

Netherlands journal of medicine, 2007-12, Vol.65 (11), p.448-451

2007

Link zum Volltext

Verfügbarkeit prüfen

Non-Hodgkin's lymphoma in the elderly: A review with emphasis on elderly patients, geriatric assessment, and future perspectives

Annals of hematology, 2003-11, Vol.82 (11), p.661-670

2003

Link zum Volltext

Verfügbarkeit prüfen

Age-related differences among patients with follicular lymphoma and the importance of prognostic scoring systems: analysis from a population-based non-Hodgkin’s lymphoma registry

Annals of oncology, 2002-08, Vol.13 (8), p.1275-1284

2002

Link zum Volltext

Verfügbarkeit prüfen

Abstract P2-09-08: Safety assessment of extended adjuvant endocrine therapy with letrozole; results of the randomized phase III IDEAL trial (BOOG 2006-05)

Cancer research (Chicago, Ill.), 2017-02, Vol.77 (4_Supplement), p.P2-P2-09-08

2017

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 93

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(76)
Mit Volltextzugriff
(77)

Publikationsform

Artikel
(89)
Tagungsberichte
(4)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(49)
Humans
(40)
Life Sciences & Biomedicine
(32)
Female
(31)
Aged
(28)
Biological And Medical Sciences
(21)
Medical Sciences
(20)
Middle Aged
(19)
Oncology
(19)
Aged, 80 And Over
(18)
Male
(18)
Physical Sciences
(17)
Physics
(16)
Adult
(13)
Physics, Applied
(13)
Hematology, Oncology And Palliative Medicine
(12)
Prognosis
(12)
Treatment Outcome
(12)
Breast Neoplasms - Drug Therapy
(11)
Breast Neoplasms - Pathology
(10)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Baseline comprehensive geriatric assessment is associated with toxicity and survival in elderly metastatic breast cancer patients receiving single-agent chemotherapy: Results from the OMEGA study of the Dutch Breast Cancer Trialists' Group

CYP2D6 genotype- and endoxifen-guided tamoxifen dose escalation increases endoxifen serum concentrations without increasing side effects

Predictive value of geriatric assessment for patients older than 70 years, treated with chemotherapy

A randomized phase III study comparing pegylated liposomal doxorubicin with capecitabine as first-line chemotherapy in elderly patients with metastatic breast cancer: results of the OMEGA study of the Dutch Breast Cancer Research Group BOOG

Clinical Relevance of BCL2, BCL6, and MYC Rearrangements in Diffuse Large B-Cell Lymphoma

Clinical Relevance of BCL2, BCL6, and MYC Rearrangements in Diffuse Large B-Cell Lymphoma

Prognostic value of geriatric assessment in older patients with advanced breast cancer receiving chemotherapy

Addition of zoledronic acid to neoadjuvant chemotherapy does not enhance tumor response in patients with HER2-negative stage II/III breast cancer: the NEOZOTAC trial (BOOG 2010-01)

Optimal duration of extended letrozole treatment after 5 years of adjuvant endocrine therapy; results of the randomized phase III IDEAL trial (BOOG 2006–05)

High non-compliance in the use of letrozole after 2.5 years of extended adjuvant endocrine therapy. Results from the IDEAL randomized trial

Factors that influence treatment decision-making in elderly DLBCL patients: a case vignette study

Patients' preferences for adjuvant chemotherapy in early-stage breast cancer: is treatment worthwhile?

Comorbidity and treatment decision-making in elderly non-Hodgkin's lymphoma patients: a survey among haematologists

Slow accrual of elderly patients with metastatic breast cancer in the Dutch multicentre OMEGA study

249 Feasibility and Toxicities Associated with PEG Doxo Versus Capecitabine as First-line Chemotherapy in Elderly Metastatic Breast Cancer (MBC) Patients; Results From the Randomized OMEGA Study of the Dutch Breast Cancer Trialists’ Group (BOOG)

Patterns of care in Dutch postmenopausal patients with hormone-sensitive early breast cancer participating in the Tamoxifen Exemestane Adjuvant Multinational (TEAM) trial

Improved survival for patients with large B-cell lymphoma after introduction of rituximab

Pulmonary coccidioidomycosis: import illness and the importance of travel history

Prognostic factors for the feasibility of chemotherapy and the Geriatric Prognostic Index (GPI) as risk profile for mortality before chemotherapy in the elderly

Abstract S1-04: Optimal duration of extended letrozole treatment after 5 years of adjuvant endocrine therapy; results of the randomized phase III IDEAL trial (BOOG 2006-05)

104 - Optimal duration of extended letrozole treatment after 5 years of adjuvant endocrine therapy; results of the randomized phase III IDEAL trial (BOOG 2006–05)

Watery diarrhoea : an unusual manifestation of breast cancer

Non-Hodgkin's lymphoma in the elderly: A review with emphasis on elderly patients, geriatric assessment, and future perspectives

Age-related differences among patients with follicular lymphoma and the importance of prognostic scoring systems: analysis from a population-based non-Hodgkin’s lymphoma registry

Abstract P2-09-08: Safety assessment of extended adjuvant endocrine therapy with letrozole; results of the randomized phase III IDEAL trial (BOOG 2006-05)

Suchergebnisse filtern